Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.
Funding Roundup
DC Devices lands $10.7M equity funding in support of transcatheter cardiac shunt
Massachusetts-based medical device startup DC Devices closed a $10.7 million funding round in support of its minimally invasive treatment for heart failure.
DC Devices "seeks to become the leading medical device company for the treatment of congestive heart failure," according to its page on the website of venture capital firm General Catalyst.
Funding: Topera Medical raises $25 million
Medical device start-up Topera Medical closed a $25 million funding round, according to federal Securities & Exchange Commission filings.
The San Diego, Calif.-based startup, which came out of stealth mode at the Heart Rhythm Society meeting last year, has FDA 510(k) clearance for its RhythmView 3D mapping system, which treats patients with cardiac rhythm disorders by targeting treatment on electrical "hot spots" in the heart.
Israeli acid reflux treatment group closes $8M private placement
Israel-based medical device maker Medigus Ltd. closed a $8 million private placement in support of its SRS Endoscopic system, a minimally invasive treatment for gastroesophageal reflux disease.
The round was sold to OrbiMed Israel Partners Limited Partnership which received 39.9 million shares of Medigus, representing 30.7% of the company.
EyeTechCare raises $13M for ultrasound glaucoma treatment
EyeTechCare said it landed nearly $13 million in its 3rd round of funding, aiming to use the cash to fund a clinical trial of its EyeOP1 ultrasound glaucoma treatment, which has been on the market in Europe since
Rillieux-la-Pape, France-based EyeTechCare said the backers include private investor Dr. Bernard Chauvin and prior investors Omnes Capital and France’s SHAM insurance company.
Avedro lands $43M in Series D financing round
Medical device company Avedro finished up a $43 million Series D financing round this week with the help of a pair of new investors, venture capital shops Third Point and Abingworth.
To tie the knot, Avedro is bringing on 2 new board members from its latest backers, Abingworth’s David Maye and Jason Hong of Third Point.
Avedro’s products are used primarily in support of Lasik laser eye surgery. The company is currently wrapping up Phase III clinical trials. Currently, none of the company’s products are for sale in the U.S.
Venezuelan currency shift lowers Johnson & Johnson’s Q1 outlook | Wall Street Beat
Healthcare giant Johnson & Johnson (NYSE:JNJ) expects to incur a charge of about $100 million in its 1st quarter of 2013 due to the negative impact of the Venezuelan government’s decision to devalue its currency, the company reported in a regulatory filing.
Funding: Nevro Corp. lands $48M in support of spinal cord stimulation tech
Weight loss: EnteroMedics closes $13M round | Wall Street Beat
EnteroMedics (NSDQ:ETRM) said it closed a public offering it expects to add about $12 million to its coffers after it pays off expenses.
The St. Paul, Minn.-based medical device company is developing technology to treat obesity using neurostimulation of the vagus nerve to suppress the appetite.
CardioKinetix closes $23M tranche in $48M Series E round
CardioKinetix said it’s raised $48 million in its Series E round with the closure of a 2nd tranche worth $23 million and plans to use the proceeds to further its Parachute ventricular partitioning device, which is in a pivotal trial.